Lyra Therapeutics Inc

NASDAQ: LYRA
$0.09
+$0.00 (+-0.4%)
Closing Price on April 23, 2025

LYRA Stock Chart and Intraday Price

LYRA Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Address 480 ARSENAL STREET, WATERTOWN, MA, US
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 299.08M USD
Shares Outstanding 52,563,000
Lyra Therapeutics Inc is a pioneering biotech firm dedicated to advancing the treatment of ear, nose, and throat diseases. With its innovative XTreo technology platform, Lyra aims to revolutionize patient care by delivering medications directly to the affected areas for extended periods with just a single application. The company is actively developing LYR-210, a promising anti-inflammatory treatment for chronic rhinosinusitis, currently in Phase II trials. Originally known as 480 Biomedical, Inc., Lyra rebranded in 2018 and is based in Watertown, Massachusetts.

LYRA Articles

When a raging bull market dies and turns into a bear market with a deep recession in less than 45 days, things are not normal. The same is true when the stock market recovers about two-thirds of its...